Literature DB >> 15842437

Electrocardiographic follow-up of biventricular pacemakers.

S Serge Barold1, Bengt Herweg, Michael Giudici.   

Abstract

Multisite pacing for the treatment of heart failure has added a new dimension to the electrocardiographic evaluation of device function. During left ventricular (LV) pacing from the appropriate site in the coronary venous system, a correctly positioned lead V1 registers a right bundle branch block pattern with few exceptions. During biventricular stimulation associated with right ventricular (RV) apical pacing, the QRS is often positive in lead V1. The frontal plane QRS axis is usually in the right superior quadrant and occasionally in the left superior quadrant. Barring incorrect placement of lead V1 (too high on the chest), lack of LV capture, LV lead displacement or marked latency (exit block or delay from the stimulation site), ventricular fusion with the spontaneous QRS complex, a negative QRS complex in lead V1 during biventricular pacing involving the RV apex probably reflects different activation of an heterogeneous biventricular substrate (ischemia, scar, His-Purkinje participation in view of the varying patterns of LV activation in spontaneous left bundle branch block) and does not necessarily indicate a poor (electrical or mechanical) contribution from LV stimulation. In this situation, it is imperative to rule out the presence of coronary venous pacing via the middle cardiac vein or even unintended placement of two leads in the RV. During biventricular pacing with the RV lead in the outflow tract, the paced QRS in lead V1 is often negative and the frontal plane paced QRS axis is often directed to the right inferior quadrant (right axis deviation). In patients with sinus rhythm and a relatively short PR interval, ventricular fusion with competing native conduction during biventricular pacing may cause misinterpretation of the ECG because narrowing of the paced QRS complex simulates appropriate biventricular capture. This represents a common pitfall in device follow-up. Elimination of ventricular fusion by shortening the AV delay, is often associated with clinical improvement. Anodal stimulation may complicate threshold testing and should not be misinterpreted as pacemaker malfunction. One must be cognizant of the various disturbances that can disrupt 1:1 atrial tracking and cause loss of ventricular resynchronization. (1) Upper rate response. The upper rate response of biventricular pacemakers differs from the traditional Wenckebach upper rate response of conventional antibradycardia pacemakers because heart failure patients generally do not have sinus bradycardia or AV junctional conduction delay. The programmed upper rate should be sufficiently fast to avoid loss of resynchronization in situations associated with sinus tachycardia. (2) Below the programmed upper rate. This may be caused by a variety of events (especially ventricular premature complexes and favored by the presence of first-degree AV block) that alter the timing of sensed and paced events. In such cases, atrial events become trapped into the postventricular atrial refractory period at atrial rates below the programmed upper rate in the presence of spontaneous AV conduction. Algorithms are available to restore resynchronization by automatic temporary abbreviation of the postventricular atrial refractory period.

Entities:  

Mesh:

Year:  2005        PMID: 15842437      PMCID: PMC6932453          DOI: 10.1111/j.1542-474X.2005.10201.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  47 in total

1.  Inappropriate tachycardia detection by a biventricular implantable cardioverter defibrillator.

Authors:  Emilio Garcia-Moran; Lluís Mont; Josep Brugada
Journal:  Pacing Clin Electrophysiol       Date:  2002-01       Impact factor: 1.976

2.  Wenckebach upper rate response of pacemakers implanted for nontraditional indications: the other side of the coin.

Authors:  S Serge Barold; Ignacio Gallardo; Dany Sayad
Journal:  Pacing Clin Electrophysiol       Date:  2002-09       Impact factor: 1.976

3.  Inappropriate shock therapy in a heart failure defibrillator.

Authors:  T R Betts; S Allen; P R Roberts; J M Morgan
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

4.  Predicting cardiac resynchronization response by QRS duration: the long and short of it.

Authors:  David A Kass
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

5.  Double jeopardy in an implantable cardioverter defibrillator patient.

Authors:  Stéphane Garrigue; S Serge Barold; Jacques Clémenty
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

6.  Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging.

Authors:  Peter Sogaard; Henrik Egeblad; Anders K Pedersen; Won Yong Kim; Bent O Kristensen; Peter S Hansen; Peter T Mortensen
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

7.  Unusual QRS morphology associated with transvenous pacemakers. The pseudo RBBB pattern.

Authors:  H O Klein; B Beker; P Sareli; E DiSegni; H Dean; E Kaplinsky
Journal:  Chest       Date:  1985-04       Impact factor: 9.410

8.  Sequential biventricular pacing: evaluation of safety and efficacy.

Authors:  Peter T Mortensen; Peter Sogaard; Hassan Mansour; Jean Ponsonaille; Daniel Gras; Arnaud Lazarus; Wolfgang Reiser; Christine Alonso; Cecilia M Linde; Maurizio Lunati; Berthold Kramm; E Mark Harrison
Journal:  Pacing Clin Electrophysiol       Date:  2004-03       Impact factor: 1.976

Review 9.  Pacing follow up techniques and trouble shooting during biventricular pacing.

Authors:  Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

10.  Inadvertent permanent ventricular pacing from the coronary vein: an electrocardiographic, roentgenographic, and echocardiographic assessment.

Authors:  U R Shettigar; R R Loungani; C A Smith
Journal:  Clin Cardiol       Date:  1989-05       Impact factor: 2.882

View more
  8 in total

1.  P-wave locking in the postventricular atrial refractory period of cardiac resynchronization devices. Management with the Biotronik system.

Authors:  S S Barold; R X Stroobandt; B Herweg; A Kucher
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-06

2.  [17th part: Transvenous pacemaker implantation in corrected Fallot tetralogy with heart failure].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-07-13

Review 3.  Diagnosis of myocardial infarction and ischemia in the setting of bundle branch block and cardiac pacing.

Authors:  B Herweg; M B Marcus; S S Barold
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09

Review 4.  ECG Patterns In Cardiac Resynchronization Therapy.

Authors:  Antonius van Stipdonk; Sofieke Wijers; Mathias Meine; Kevin Vernooy
Journal:  J Atr Fibrillation       Date:  2015-04-30

5.  Using devices with a variable postventricular atrial refractory period for cardiac resynchronization.

Authors:  S S Barold; R X Stroobandt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

6.  Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy.

Authors:  Luigi Padeletti; Chiara Fantappiè; Laura Perrotta; Giuseppe Ricciardi; Paolo Pieragnoli; Marco Chiostri; Sergio Valsecchi; Maria Cristina Porciani; Antonio Michelucci; Fabio Fantini
Journal:  Clin Res Cardiol       Date:  2010-09-04       Impact factor: 5.460

7.  Electrocardiographic clues to identify nonresponders to cardiac resynchronization therapy.

Authors:  Firas H El Sabbagh; Osler Jay J Guzon; Martin A Alpert; Greg C Flaker
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

8.  Electrocardiographic patterns in biventricular pacing delivered by second-generation cardiac resynchronization devices.

Authors:  Amirfarjam Fazelifar; Fatemeh Jorfi; Majid Haghjoo
Journal:  Indian Pacing Electrophysiol J       Date:  2017-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.